Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)
Dr. Benny Baeten, Compound Development Team Leader for Anthelmintics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks
ISNTD Philanthropy Tobin Aldrich Sightsavers - Growth and Diversification
ISNTD Philanthropy 2014 - Tobin Aldrich - Head of Global Fundraising Sightsavers speaks about growth and diversification in fundraising and
Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017
Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine. Panelists are: • Dr. Benny Baeten (J&J...
Dr. Rita Oliveira (Imperial College London): Comparing standard and molecular diagnostics for STH
At ISNTD d³ 2017, Dr. Rita Oliveira, from Imperial College London, speaks about recent community-wide cross sectional study of Soil-Transmit
Pr. David Sattelle (University College London): The Search for New Drugs for Whipworm
At ISNTD d³ 2017, Pr. David Sattelle from University College London describes the current work at UCL to discover and develop new antihelmin
Dr. Benny Baeten (J&J Global Health): Solutions for Soil-Transmitted Helminths & Onchocercia
At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company